In intermediate-stage HCC, significant differences were observed in age, sex, American Society of Anesthesiologists score, cancer stage, platelet count, AFP levels, microvascular invasion, and liver function-related variables. This evidence concerns the gene AFP and hepatocellular carcinoma.